Effect of Mutation Type and Location on Clinical Outcome in 1,013 Probands with Marfan Syndrome or Related Phenotypes and FBN1 Mutations: An International.

Slides:



Advertisements
Similar presentations
Connexin Mutations in Skin Disease and Hearing Loss David P. Kelsell, Wei-Li Di, Mark J. Houseman The American Journal of Human Genetics Volume 68, Issue.
Advertisements

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.
Evidence for Autosomal Dominant Inheritance of Prostate Cancer
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
Recent advances in understanding Marfan syndrome: Should we now treat surgical patients with losartan?  Peter Matt, MD, Jennifer Habashi, MD, Thierry.
Volume 130, Issue 6, Pages (May 2006)
Mitral stenosis with pulmonary hypertension: We should operate early
Human Diallelic Insertion/Deletion Polymorphisms
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival  Ryan K. Van Laar 
In-Frame Mutations in Exon 1 of SKI Cause Dominant Shprintzen-Goldberg Syndrome  Virginie Carmignac, Julien Thevenon, Lesley Adès, Bert Callewaert, Sophie.
Marfan Syndrome: From Molecules to Medicines*
Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis  Evaldas Girdauskas,
Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients  Björn.
Volume 125, Issue 4, Pages (October 2003)
Volume 130, Issue 6, Pages (May 2006)
Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients  Joachim Pfannschmidt,
Endovascular repair of abdominal aortic aneurysm in octogenarians: An analysis based on EUROSTAR data  Conrad Lange, MD, Lina J. Leurs, MSc, Jaap Buth,
The Origin of Abnormalities in Recurrent Aneuploidy/Polyploidy
Correction Journal of the American College of Surgeons
The Marfan Syndrome, Coarctation of the Aorta, and Precocious Puberty
Shih-Jen Hwang, Guillermina Lozano, Christopher I. Amos, Louise C
Bartosz Rylski, MD, Friedhelm Beyersdorf, MD, PhD, Fabian A
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
Genotype-Phenotype Associations in Sotos Syndrome: An Analysis of 266 Individuals with NSD1 Aberrations  Katrina Tatton-Brown, Jenny Douglas, Kim Coleman,
Bilateral pulmonary arterial banding results in an increased need for subsequent pulmonary artery interventions  Ryan R. Davies, MD, Wolfgang A. Radtke,
Long-Term Outcomes of the Mosaic Bioprosthesis
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
Predictors of the Risk of Mortality in Neurofibromatosis 2
Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery  James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,
Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation  Michael H. Kwon,
Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis  Shahid I. Sheikh, MD, Don Hayes,
Management of patients with intramural hematoma involving the ascending aorta  Yoshimasa Moizumi, MDa, Tsunehiro Komatsu, MDa, Naotaka Motoyoshi, MDa,
Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study  J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.
Management of dilated ascending aorta during aortic valve replacement: Valve replacement alone versus aorta wrapping versus aorta replacement  Seung Hyun.
A limited and customized follow-up seems justified after endovascular abdominal aneurysm repair in octogenarians  Linda Visser, MD, Robert A. Pol, MD,
Incidence, Predisposing Factors, and Outcome of Engraftment Syndrome in Pediatric Allogeneic Stem Cell Transplant Recipients  Irene Schmid, Daniel Stachel,
Ataxia with Isolated Vitamin E Deficiency: Heterogeneity of Mutations and Phenotypic Variability in a Large Number of Families  Laurent Cavalier, Karim.
Erratum The American Journal of Human Genetics
Premature Termination Mutations in FBN1: Distinct Effects on Differential Allelic Expression and on Protein and Clinical Phenotypes  Iris Schrijver, Wanguo.
The influence of retransplantation on survival for pediatric lung transplant recipients  Ryuichi Waseda, MD, PhD, Alberto Benazzo, MD, Konrad Hoetzenecker,
Ryan McDaniell, Daniel M. Warthen, Pedro A
Characteristics of Malignant Pleural Mesothelioma in Women
Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD 
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Aortic Root Replacement for Children With Loeys-Dietz Syndrome
A fate worse than death  Jennifer S. Lawton, MD 
Socioeconomic disparities affect survival after aortic dissection
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
Norman R. Hertzer, MDa, Edward J. Mascha, MSb, Mathew T
Volume 63, Issue 2, Pages (February 2003)
E.Stanley Crawford, M.D., Ralph W. DeNatale, M.D. 
Premature Termination Mutations in FBN1: Distinct Effects on Differential Allelic Expression and on Protein and Clinical Phenotypes  Iris Schrijver, Wanguo.
Concomitant replacement of the ascending aorta is free—for some
Volume 62, Issue 5, Pages (November 2002)
Michael A. Coady, MD, John A. Rizzo, PhD, Graeme L
Creating functional autogenous vascular access in older patients
Prophylactic stage 1 elephant trunk for moderately dilated descending aorta in patients with predominantly proximal disease  Jay J. Idrees, MD, Eric E.
Repair of Truncus Arteriosus and Aortic Arch Interruption: Outcome Analysis  Takashi Miyamoto, MD, Nicodème Sinzobahamvya, MD, Daiva Kumpikaite, MD, Boulos.
Surgical outcomes after cardiac surgery in liver transplant recipients
Chan B. Park, MD, Kevin L. Greason, MD, Rakesh M. Suri, MD, Hector I
Should patient age be a consideration in carotid endarterectomy?
NSD1 Mutations Are the Major Cause of Sotos Syndrome and Occur in Some Cases of Weaver Syndrome but Are Rare in Other Overgrowth Phenotypes  Jenny Douglas,
Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer  Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,
Total Anomalous Pulmonary Venous Connection: An Analysis of Current Management Strategies in a Single Institution  Camille L. Hancock Friesen, MD, David.
Evidence for Autosomal Dominant Inheritance of Prostate Cancer
Alice S. Whittemore, Jerry Halpern 
Early and 1-year outcomes of aortic root surgery in patients with Marfan syndrome: A prospective, multicenter, comparative study  Joseph S. Coselli, MD,
Melanie D. Everitt, MD, Nelangi Pinto, MD, John A. Hawkins, MD, Max B
(A). (A). Kaplan-Meier plot of event-free survival in 27 LMNA mutation carriers and 78 DCM control patients. Death, heart transplantation, resuscitation.
Risk factors for primary graft dysfunction after lung transplantation
Presentation transcript:

Effect of Mutation Type and Location on Clinical Outcome in 1,013 Probands with Marfan Syndrome or Related Phenotypes and FBN1 Mutations: An International Study  L. Faivre, G. Collod-Beroud, B.L. Loeys, A. Child, C. Binquet, E. Gautier, B. Callewaert, E. Arbustini, K. Mayer, M. Arslan-Kirchner, A. Kiotsekoglou, P. Comeglio, N. Marziliano, H.C. Dietz, D. Halliday, C. Beroud, C. Bonithon-Kopp, M. Claustres, C. Muti, H. Plauchu, P.N. Robinson, L.C. Adès, A. Biggin, B. Benetts, M. Brett, K.J. Holman, J. De Backer, P. Coucke, U. Francke, A. De Paepe, G. Jondeau, C. Boileau  The American Journal of Human Genetics  Volume 81, Issue 3, Pages 454-466 (September 2007) DOI: 10.1086/520125 Copyright © 2007 The American Society of Human Genetics Terms and Conditions

Figure 1 Types of FBN1 mutations included in the study. Of 1,013, 573 (56%) could be classified as missense mutations, 170 (17%) as frameshift mutations, 137 (14%) as nonsense mutations, 110 (11%) as splicing mutations, and 23 (2%) as inframe deletions or insertions. The American Journal of Human Genetics 2007 81, 454-466DOI: (10.1086/520125) Copyright © 2007 The American Society of Human Genetics Terms and Conditions

Figure 2 Kaplan-Meier analyses for the probability of ectopia lentis diagnoses for patients with different types of mutations. A, Probability of ectopia lentis in PTC versus inframe mutations. The cumulative probability of diagnosis of ectopia lentis before or at age 25 years was 23% (99.9% CI 15%–32%) for patients with PTC mutations (thin line) compared with 50% (99.9% CI 43%–57%) for patients with inframe mutations (thick line) (log-rank test P<.0001). B, Probability of ectopia lentis for patients with missense mutation involving a cysteine versus other missense mutations. The cumulative probability of diagnosis of ectopia lentis before or at age 25 years was 59% (99.9% CI 50%–68%) for patients with missense mutations involving a cysteine (thin line) compared with 32% (99.9% CI 22%–44%) for patients with other missense mutations (thick line) (log-rank test P<.0001). The American Journal of Human Genetics 2007 81, 454-466DOI: (10.1086/520125) Copyright © 2007 The American Society of Human Genetics Terms and Conditions

Figure 3 Frequency of skeletal, skin, pulmonary, and dural phenotypes in study participants with PTC mutations (gray bars), compared with those with inframe mutations (black bars). An asterisk (*) indicates that differences between groups were statistically significant (MH test P<.001). The American Journal of Human Genetics 2007 81, 454-466DOI: (10.1086/520125) Copyright © 2007 The American Society of Human Genetics Terms and Conditions

Figure 4 Kaplan-Meier analyses for the probability of MFS clinical-features diagnosis for patients with different locations of mutations. A, Age at diagnosis of type I fibrillinopathy with a mutation in exons 24–32 versus in other exons. Fifty percent of patients with a mutation in exons 24–32 (thin line) received a diagnosis at age 9 years (IQR 1–24 years) versus age 24 years (IQR 12–35 years) of patients with a mutation in other exons (thick line) (log-rank test P<.0001). B, Survival of patients with mutations in exons 24–32 versus in other exons. Seventy-six percent of patients with mutations within exons 24–32 (thin line) were alive at age 40 years (99.9%CI 61%–87% years) compared with 98% (99.9% CI 93%–99%) of patients with mutations located in other exons (thick line) (log-rank test P<.0001). C, Probability of diagnosing a dilatation of the ascending aorta for patients with mutations in exons 24–32 versus in other exons. The cumulative probability of diagnosis of ascending aortic dilatation before or at age 40 years was 87% (99.9% CI 77%–95%) for patients with mutations in exons 24–32 (thin line) compared with 72% (99.9% CI 67%–78%) for patients with mutations in other exons (thick line) (log-rank test P<.0001). D, Probability of aortic surgery for patients with mutations in exons 24–32 versus in other exons. The cumulative probability of aortic surgery before or at age 40 years was 55% (99.9% CI 35%–77%) for patients with mutations in exons 24–32 (thin line) compared with 38% (99.9% CI 30%–48%) for patients with mutations in other exons (thick line) (log-rank test P<.0001). E, Probability of ectopia lentis for patients with mutations in exons 24–32 versus in other exons. The cumulative probability of ectopia lentis diagnosis before or at age 25 years was 53% (99.9% CI 39%–67%) for patients with mutations in exons 24–32 (thin line) compared with 38% (99.9% CI 33%–44%) for patients with mutations in other exons (thick line) (log-rank test P=.0003). F, Probability of scoliosis for patients with mutations in exons 24–32 versus in other exons. The cumulative probability of scoliosis diagnosis before or at age 25 years was 61% (99.9% CI 47%–75%) for patients with mutations in exons 24–32 (thin line) compared with 44% (99.9% CI 38%–51%) for patients with mutations in other exons (thick line) (log-rank test P<.0001). The American Journal of Human Genetics 2007 81, 454-466DOI: (10.1086/520125) Copyright © 2007 The American Society of Human Genetics Terms and Conditions